TARS - Tarsus Pharmaceuticals, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Tarsus Pharmaceuticals, Inc. Common Stock
IPO Date: October 12, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $3.38B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.00 | 2.96%
Avg Daily Range (30 D): $1.91 | 2.44%
Avg Daily Range (90 D): $1.74 | 2.56%
Institutional Daily Volume
Avg Daily Volume: .32M
Avg Daily Volume (30 D): .55M
Avg Daily Volume (90 D): .69M
Trade Size
Avg Trade Size (Sh.): 55
Avg Trade Size (Sh.) (30 D): 46
Avg Trade Size (Sh.) (90 D): 53
Institutional Trades
Total Institutional Trades: 2,158
Avg Institutional Trade: $3.29M
Avg Institutional Trade (30 D): $4.8M
Avg Institutional Trade (90 D): $4.42M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.73M
Avg Closing Trade (30 D): $7.86M
Avg Closing Trade (90 D): $6.75M
Avg Closing Volume: 78.98K
 
News
Aug 6, 2026 @ 12:02 AM
Tarsus to Report Second Quarter 2026 Financial Res...
Source: Na
May 7, 2026 @ 9:00 PM
Tarsus to Participate in Upcoming Investor Confere...
Source: Not Specified
Mar 24, 2026 @ 5:06 PM
Tarsus Pharma Stock Up 20% as Insider Sells $839K ...
Source: Jonathan Ponciano
Oct 28, 2025 @ 9:00 PM
Tarsus to Report Third Quarter 2025 Financial Resu...
Source: Tarsus Pharmaceuticals, Inc.
Oct 27, 2025 @ 3:15 PM
Capricorn Fund Loads Up on Phreesia (PHR) With a 4...
Source: Cory Renauer
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.43 $-.16 $-.19
Diluted EPS $-.43 $-.16 $-.19
Revenue $173.91M $162.05M $151.67M
Gross Profit $161.8M $152.66M
Net Income / Loss $-18.55M $-6.97M $-8.37M
Operating Income / Loss $-19.91M $-6.12M $-7.98M
Cost of Revenue $12.11M $9.4M
Net Cash Flow $102.4M $-82.01M $70.92M
PE Ratio